Lipidomic profiling reveals time-resolved oxylipin responses to severe burn injury
BACKGROUND: Severe burn injuries affecting more than 40% of the total body surface area (TBSA) are associated with a high risk of mortality. Clinically, burn injury is accompanied by increased systemic inflammation, adipose tissue lipolysis, and skeletal muscle catabolism that can contribute to muscle wasting. Despite the well-established role of inflammation in mediating these processes, the role of circulating oxylipins, released from various tissues and potentially linked to the inflammatory response, remains poorly understood. METHODS: In this study, we investigated the temporal dynamics of plasma oxylipins in male and female patients with severe burn injuries (n = 7, mean TBSA 61 ± 6%) over a 33-day period post-injury, using high-resolution lipidomic profiling. A total of 114 lipid species were quantified, revealing distinct time-dependent alterations in both pro-inflammatory and anti-inflammatory lipid mediators. In addition, selected oxylipins were evaluated in C2C12 myotubes to test whether they engage atrophy-related and inflammatory transcriptional programs. RESULTS: Specifically, levels of the pro-inflammatory oxylipins 15-hydroxyeicosatetraenoic acid (15-HETE) and its downstream metabolite 15-oxo-eicosatetraenoic acid (15-oxoETE) were elevated immediately after injury, whereas the anti-inflammatory oxylipin resolvin D1 (RvD1) peaked during the later phase of recovery. C2C12 myotubes incubated with 15-oxoETE increased expression of genes involved in muscle protein catabolism and inflammation, while co-incubation with RvD1 attenuated this transcriptional response. CONCLUSION: These findings define dynamic changes in the plasma lipidome following severe burn injury and identify selected burn-regulated oxylipins that can modulate skeletal muscle stress- and catabolism-related transcriptional programs in vitro.
Authors
- Valerie Bussberg (ORCID: https://orcid.org/0009-0003-6830-3788)
- Michael A. Kiebish (ORCID: https://orcid.org/0000-0002-5678-0072)
- Shinsuke Nirengi (ORCID: https://orcid.org/0000-0003-1881-067X)
- Charles E. Wade (ORCID: https://orcid.org/0000-0003-0055-5885)
- Nickolai P. Seculov (ORCID: https://orcid.org/0000-0002-2655-7232)
- Kristin I. Stanford (ORCID: https://orcid.org/0000-0002-0681-7746)
- Lisa A. Baer
- Kendra Madaris
- Diego Hernandez-Saavedra
- Revati S. Dewal
Institutions
- University of Illinois Urbana-Champaign (US)
- The Ohio State University Wexner Medical Center (US)
- BG Medicine (United States) (US)
- The Ohio State University (US)
Publication Details
- Journal
- Lipids in Health and Disease
- Published
- 2026-07-17
- DOI
- https://doi.org/10.1186/s12944-026-03016-y
- Primary Topic
- Eicosanoids and Hypertension Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Heart Association
- National Institute of Diabetes and Digestive and Kidney Diseases